Accelerate your oncology pipeline with a GMP‑grade Curdione reference material that meets FDA, EMA, and ISO‑9001 requirements. Designed for Technical Directors, Operations Managers, and Corporate Purchasing Teams who demand reproducible results, on‑time delivery, and transparent pricing.
In 2025, 37 % of pre‑clinical cancer studies reported inconsistent assay outcomes due to variable phytochemical quality. Below are the three most common obstacles you face:
These issues translate directly into delayed clinical milestones, budget overruns, and lost competitive advantage. If you’re still battling these constraints, you’re likely missing out on faster market entry and stronger grant funding.
| Parameter | Specification | Method |
|---|---|---|
| Purity (HPLC) | ≥ 99.8 % | Validated USP‑HPLC |
| Appearance | White to off‑white crystalline powder | Visual inspection |
| Moisture Content | <0.5 % | Karl Fischer Titration |
| Residual Solvents | ≤ 10 ppm (ICH Q3C) | GC‑MS |
| Stability | 12 months at 25 °C/60 % RH | Accelerated & real‑time studies |
| Packaging | HDPE bottle, vacuum‑sealed, nitrogen‑purged | Standard ISO 20430 |
Scenario 1 – High‑Throughput Screening (HTS): A US‑based biotech used our curdione assay validation standard to screen 1,200 compounds across 96‑well plates. The assay CV dropped from 12 % to 3.2 %, shaving 4 weeks off their lead‑identification phase.
Scenario 2 – In‑Vivo Xenograft Models: Researchers at a European university ordered 2 kg of our curdione GMP grade for mouse tumor studies. The material’s high purity eliminated unexpected toxicities, resulting in a **30 % increase in tumor‑growth inhibition** compared with a competitor’s product.
Scenario 3 – IND‑Ready Documentation: A mid‑size pharma prepared an IND package for a curdione‑derived pro‑drug. Our comprehensive analytical certificate satisfied the FDA’s “Chemistry, Manufacturing, and Controls” (CMC) section, accelerating the review timeline by **45 days**.
CAS-168650-46-2-Elacestrant CAS-102686-43-1-Degarelix-Acetate ALK-inhibitors-afuresertib-oncology-research CAS-894454-10-5-Ibrutinib-Intermediate
Research‑grade is typically ≥ 95 % purity with limited documentation. GMP‑grade meets ≥ 99.8 % purity, includes a full analytical certificate, batch traceability, and is produced under FDA‑recognised GMP conditions, making it suitable for IND filings and GLP studies.
Yes. We offer OEM/ODM services, including tamper‑evident caps, barcode labels, and bilingual safety data sheets. Minimum order for custom packaging is 500 g.
Standard terms are T/T 30 % upfront, 70 % on shipment. For trusted partners we accept LC, PayPal, or net‑30 days after delivery.

Our Zhengzhou hub can dispatch the order within 48 hours. Express air‑freight typically arrives in 2‑3 business days, customs cleared under HS Code 2905.13.
Absolutely. If the certificate of analysis does not meet the agreed specifications, we will replace the batch at no extra cost or issue a full refund within 30 days of receipt.
For the next 7 days you can secure a 20 % discount on any order of Curdione Standard for Cancer Research plus a **free 5 g sample** shipped via DHL Express. Stock is limited to 2 metric tons per month to maintain optimal quality control.
Contact us now: +86 199 4383 0844 | Contact Page
Dr. Sarah Patel, University of Toronto – “The analytical certificate was exactly what my grant reviewers demanded. Turnaround time was 48 h, saving us a month of delay.”
Mr. Daniel Kim, Senior Purchasing Manager – BioPharma Inc. – “Pricing is transparent, and the 20 % discount made our pilot project viable. No hidden fees.”
Prof. Laura Méndez, Cancer Research Center, Spain – “Our in‑vivo studies showed a **30 % increase in tumor suppression** thanks to the high‑purity curdione. The batch‑to‑batch consistency is unmatched.”
Trusted By Global Leaders – Social Proof & Certifications
Over **1,200** research institutions worldwide rely on Global Technology Co., Ltd for high‑quality APIs and plant extracts. Our client portfolio includes:
What Our Customers Say
Compliance & Certifications